These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10211889)

  • 21. Granulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current Knowledge.
    Wojciechowska J; Krajewski W; Krajewski P; Kręcicki T
    Clin Exp Otorhinolaryngol; 2016 Mar; 9(1):8-13. PubMed ID: 26976020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokines: Names and Numbers You Should Care About.
    Holdsworth SR; Gan PY
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2243-54. PubMed ID: 25941193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophils in vasculitis: characteristics and roles in pathogenesis.
    Khoury P; Grayson PC; Klion AD
    Nat Rev Rheumatol; 2014 Aug; 10(8):474-83. PubMed ID: 25003763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).
    Langford CA; Monach PA; Specks U; Seo P; Cuthbertson D; McAlear CA; Ytterberg SR; Hoffman GS; Krischer JP; Merkel PA;
    Ann Rheum Dis; 2014 Jul; 73(7):1376-9. PubMed ID: 24323392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy.
    Wilde B; Thewissen M; Damoiseaux J; Hilhorst M; van Paassen P; Witzke O; Cohen Tervaert JW
    Arthritis Res Ther; 2012 Oct; 14(5):R227. PubMed ID: 23079279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?
    Wilde B; Thewissen M; Damoiseaux J; van Paassen P; Witzke O; Tervaert JW
    Arthritis Res Ther; 2010; 12(1):204. PubMed ID: 20236453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells.
    Morgan MD; Day CJ; Piper KP; Khan N; Harper L; Moss PA; Savage CO
    Immunology; 2010 May; 130(1):64-73. PubMed ID: 20113371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis.
    Wieczorek S; Holle JU; Müller S; Fricke H; Gross WL; Epplen JT
    J Mol Med (Berl); 2010 Apr; 88(4):413-21. PubMed ID: 20049410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients.
    Ordonez L; Bernard I; L'faqihi-Olive FE; Tervaert JW; Damoiseaux J; Saoudi A
    PLoS One; 2009; 4(4):e5287. PubMed ID: 19381293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis.
    Novick D; Elbirt D; Dinarello CA; Rubinstein M; Sthoeger ZM
    J Clin Immunol; 2009 Jan; 29(1):38-45. PubMed ID: 18594952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Lee RW; D'Cruz DP
    Drugs; 2008; 68(6):747-70. PubMed ID: 18416584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.
    Aouba A; Pagnoux C; Bienvenu B; Mahr A; Guillevin L
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):65-73. PubMed ID: 18270860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypereosinophilic syndrome and Churg-Strauss syndrome: is it clinically relevant to differentiate these syndromes?].
    Hellmich B; Holl-Ulrich K; Merz H; Gross WL
    Internist (Berl); 2008 Mar; 49(3):286-96. PubMed ID: 18214408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-cell depletion in Wegener's granulomatosis.
    Hinze CH; Colbert RA
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):372-9. PubMed ID: 18172780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiling in granulomatous lung disease.
    Chen ES; Moller DR
    Proc Am Thorac Soc; 2007 Jan; 4(1):101-7. PubMed ID: 17202298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides.
    Becker H; Maaser C; Mickholz E; Dyong A; Domschke W; Gaubitz M
    Clin Rheumatol; 2006 May; 25(3):368-72. PubMed ID: 16391884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasal Wegener's and skin sarcoid--a rare combination of two granulomatous diseases.
    Kuttikat A; Saeed T; Chopra B; Chopra S; Chakravarty K
    Clin Rheumatol; 2006 Nov; 25(6):895-7. PubMed ID: 16283416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
    Aries PM; Hellmich B; Voswinkel J; Both M; Nölle B; Holl-Ulrich K; Lamprecht P; Gross WL
    Ann Rheum Dis; 2006 Jul; 65(7):853-8. PubMed ID: 16269425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.
    Lamprecht P
    Clin Exp Immunol; 2005 Aug; 141(2):201-10. PubMed ID: 15996183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.
    Marinaki S; Neumann I; Kälsch AI; Grimminger P; Breedijk A; Birck R; Schmitt W; Waldherr R; Yard BA; Van Der Woude FJ
    Clin Exp Immunol; 2005 Apr; 140(1):181-91. PubMed ID: 15762890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.